New Medicine Service (NMS)

New Medicine Service (NMS)

The New Medicine Service (NMS) was the fourth Advanced Service to be added to the Community Pharmacy Contractual Framework; it commenced on 1st October 2011.

The service provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is focused on particular patient groups and conditions.

Since the introduction of the NMS, more than 90% of community pharmacies in England have provided it to their patients.

To inform the longer-term commissioning decision, the Department of Health (DH) commissioned researchers at the University of Nottingham to lead an academic evaluation of the service, investigating both the clinical and economic benefits of it. The findings from the evaluation were published in August 2014 and were overwhelmingly positive, with the researchers concluding that as the NMS delivered better patient outcomes for a reduced cost to the NHS, it should be continued. This was the basis for NHS England’s firm decision to continue commissioning the service.

Click on a heading below for more information.

Directions, guidance and service specification

The legal basis for the service is provided by the Secretary of State Directions. The service specification provides a ‘plain English’ version of the Directions and the official guidance from PSNC and NHS Employers provides essential information on the service for community pharmacy contractors, their staff and local NHS England teams (the successor bodies to PCTs).

The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013

These Directions have been amended a number of times since publication. The amendment Directions are printed in the Drug Tariff. PSNC has created a document which consolidates the 2013 Directions and subsequent amendments made up to December 2016.

NMS service specification (August 2013)

PSNC and NHS Employers guidance on the NMS for contractors, their staff and local NHS England teams (updated in December 2013 to reflect the NHS re-organisation). Since this guidance was published, a change to the NMS reporting requirements has taken place since publication and therefore some aspects of the guidance document are now out of date. This PSNC document details the parts of the joint guidance which are now out of date and should be read alongside the joint guidance document.

Related resources

PSNC Briefing 033/15: Services Factsheet – NMS Medicines List (July 2015)
This Briefing outlines the requirements for patients to be eligible to receive the NMS service.

PSNC Briefing 087/13: Advanced services and Pre-registration Trainees (20th August 2013)
Following media reports that pre-registration trainees have been allowed to provide MUR and NMS consultations without supervision by a pharmacist, PSNC has issued guidance to pharmacy contractors.

NMS and MURs – top tips from community pharmacies

Click on a heading below for more information. 

Notifying NHS England

Pharmacist knowledge and skills requirements

NMS medicines list

Providing the NMS

Obtaining patient consent

Patient information

Interview schedule

NMS record keeping and NHSBSA reporting requirements

Post-payment verification process

Communicating with GPs

Referring patients to GPs

Working with hospital colleagues

Funding and claiming payment

Service evaluation

NMS statistics

Other information


Further NMS resources

Latest Services and Commissioning news

View more Services and Commissioning news >